Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 46% ± 13% | |
lung | 17 studies | 52% ± 18% | |
intestine | 12 studies | 43% ± 21% | |
kidney | 9 studies | 52% ± 14% | |
eye | 8 studies | 41% ± 17% | |
bone marrow | 6 studies | 35% ± 15% | |
brain | 6 studies | 36% ± 12% | |
liver | 6 studies | 48% ± 24% | |
lymph node | 5 studies | 48% ± 19% | |
uterus | 5 studies | 46% ± 24% | |
pancreas | 4 studies | 56% ± 20% | |
prostate | 4 studies | 39% ± 10% | |
breast | 4 studies | 40% ± 6% | |
placenta | 3 studies | 63% ± 26% | |
adrenal gland | 3 studies | 46% ± 6% | |
esophagus | 3 studies | 58% ± 27% | |
skin | 3 studies | 35% ± 7% | |
thymus | 3 studies | 62% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 3092.58 | 966 / 966 | 100% | 100.16 | 527 / 527 |
ovary | 100% | 1816.02 | 180 / 180 | 100% | 206.94 | 430 / 430 |
stomach | 100% | 2636.41 | 359 / 359 | 100% | 112.73 | 286 / 286 |
uterus | 100% | 1989.09 | 170 / 170 | 100% | 64.09 | 459 / 459 |
skin | 100% | 3186.50 | 1808 / 1809 | 100% | 54.07 | 472 / 472 |
esophagus | 100% | 3169.15 | 1444 / 1445 | 100% | 114.99 | 183 / 183 |
brain | 100% | 3833.37 | 2637 / 2642 | 100% | 56.72 | 705 / 705 |
prostate | 100% | 3315.04 | 245 / 245 | 100% | 59.60 | 501 / 502 |
bladder | 100% | 2364.43 | 21 / 21 | 100% | 76.93 | 502 / 504 |
breast | 100% | 2721.11 | 459 / 459 | 99% | 46.09 | 1111 / 1118 |
liver | 100% | 2788.96 | 225 / 226 | 100% | 53.14 | 404 / 406 |
kidney | 100% | 4651.13 | 89 / 89 | 99% | 42.56 | 892 / 901 |
lung | 99% | 2491.20 | 575 / 578 | 99% | 59.41 | 1149 / 1155 |
adrenal gland | 100% | 4080.09 | 258 / 258 | 99% | 40.00 | 227 / 230 |
pancreas | 99% | 1523.75 | 325 / 328 | 99% | 47.73 | 176 / 178 |
thymus | 100% | 2628.83 | 653 / 653 | 98% | 39.39 | 591 / 605 |
lymph node | 0% | 0 | 0 / 0 | 100% | 81.62 | 29 / 29 |
muscle | 100% | 5004.31 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2821.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 46.06 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 54.04 | 1 / 1 |
adipose | 100% | 2711.53 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 2064.99 | 1326 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 40.96 | 79 / 80 |
heart | 98% | 6213.02 | 848 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 2382.15 | 842 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042776 | Biological process | proton motive force-driven mitochondrial ATP synthesis |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0015986 | Biological process | proton motive force-driven ATP synthesis |
GO_0005753 | Cellular component | mitochondrial proton-transporting ATP synthase complex |
GO_0031965 | Cellular component | nuclear membrane |
GO_0045263 | Cellular component | proton-transporting ATP synthase complex, coupling factor F(o) |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0046933 | Molecular function | proton-transporting ATP synthase activity, rotational mechanism |
Gene name | ATP5MF |
Protein name | ATP synthase subunit f, mitochondrial (ATP synthase membrane subunit f) ATP synthase membrane subunit f |
Synonyms | ATP5JL ATP5J2 |
Description | FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain. Minor subunit located with subunit a in the membrane. FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain. Minor subunit located with subunit a in the membrane. . |
Accessions | ENST00000449683.5 ENST00000523680.1 C9JU26 ENST00000488775.5 [P56134-4] ENST00000414062.5 [P56134-4] ENST00000394186.3 [P56134-2] P56134 ENST00000292475.8 [P56134-1] ENST00000359832.8 [P56134-3] E5RKA0 |